177 related articles for article (PubMed ID: 32680929)
1. Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.
Barrington SF; Zwezerijnen BGJC; de Vet HCW; Heymans MW; Mikhaeel NG; Burggraaff CN; Eertink JJ; Pike LC; Hoekstra OS; Zijlstra JM; Boellaard R
J Nucl Med; 2021 Mar; 62(3):332-337. PubMed ID: 32680929
[TBL] [Abstract][Full Text] [Related]
2. Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim
Zwezerijnen GJC; Eertink JJ; Burggraaff CN; Wiegers SE; Shaban EAIN; Pieplenbosch S; Oprea-Lager DE; Lugtenburg PJ; Hoekstra OS; de Vet HCW; Zijlstra JM; Boellaard R
J Nucl Med; 2021 Nov; 62(11):1531-1536. PubMed ID: 33674403
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in
Driessen J; Zwezerijnen GJC; Schöder H; Drees EEE; Kersten MJ; Moskowitz AJ; Moskowitz CH; Eertink JJ; Vet HCW; Hoekstra OS; Zijlstra JM; Boellaard R
J Nucl Med; 2022 Sep; 63(9):1424-1430. PubMed ID: 34992152
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
Eertink JJ; Pfaehler EAG; Wiegers SE; van T; Brug D; Lugtenburg PJ; Hoekstra OS; Zijlstra JM; de Vet HCW; Boellaard R
J Nucl Med; 2022 Mar; 63(3):389-395. PubMed ID: 34272315
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma.
Burggraaff CN; Rahman F; Kaßner I; Pieplenbosch S; Barrington SF; Jauw YWS; Zwezerijnen GJC; Müller S; Hoekstra OS; Zijlstra JM; De Vet HCW; Boellaard R;
Mol Imaging Biol; 2020 Aug; 22(4):1102-1110. PubMed ID: 31993925
[TBL] [Abstract][Full Text] [Related]
6. Combatting the effect of image reconstruction settings on lymphoma [
Ferrández MC; Eertink JJ; Golla SSV; Wiegers SE; Zwezerijnen GJC; Pieplenbosch S; Zijlstra JM; Boellaard R
EJNMMI Res; 2022 Jul; 12(1):44. PubMed ID: 35904645
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
8. Deep-Learning
Capobianco N; Meignan M; Cottereau AS; Vercellino L; Sibille L; Spottiswoode B; Zuehlsdorff S; Casasnovas O; Thieblemont C; Buvat I
J Nucl Med; 2021 Jan; 62(1):30-36. PubMed ID: 32532925
[TBL] [Abstract][Full Text] [Related]
9. Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.
Mikhaeel NG; Smith D; Dunn JT; Phillips M; Møller H; Fields PA; Wrench D; Barrington SF
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1209-19. PubMed ID: 26902371
[TBL] [Abstract][Full Text] [Related]
10. To evaluate prognostic significance of metabolic-derived tumour volume at staging 18-flurodeoxyglucose PET-CT scan and to compare it with standardized uptake value-based response evaluation on interim 18-flurodeoxyglucose PET-CT scan in patients of non-Hodgkin's lymphoma (diffuse large B-cell lymphoma).
Gupta N; Singh N
Nucl Med Commun; 2020 Apr; 41(4):395-404. PubMed ID: 32073552
[TBL] [Abstract][Full Text] [Related]
11. Functional Parameters of
Yang J; Zhu S; Pang F; Xu M; Dong Y; Hao J; Ma X
Contrast Media Mol Imaging; 2018; 2018():8659826. PubMed ID: 30363729
[TBL] [Abstract][Full Text] [Related]
12. Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
Xu W; Yu S; Ma Y; Liu C; Xin J
Nucl Med Commun; 2017 Mar; 38(3):259-265. PubMed ID: 28118260
[TBL] [Abstract][Full Text] [Related]
13. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
[TBL] [Abstract][Full Text] [Related]
14. High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.
Song MK; Yang DH; Lee GW; Lim SN; Shin S; Pak KJ; Kwon SY; Shim HK; Choi BH; Kim IS; Shin DH; Kim SG; Oh SY
Leuk Res; 2016 Mar; 42():1-6. PubMed ID: 26851438
[TBL] [Abstract][Full Text] [Related]
15. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.
Ilyas H; Mikhaeel NG; Dunn JT; Rahman F; Møller H; Smith D; Barrington SF
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1142-1154. PubMed ID: 29460024
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT
Cottereau AS; Meignan M; Nioche C; Capobianco N; Clerc J; Chartier L; Vercellino L; Casasnovas O; Thieblemont C; Buvat I
Ann Oncol; 2021 Mar; 32(3):404-411. PubMed ID: 33278600
[TBL] [Abstract][Full Text] [Related]
17. Texture Analysis Improves the Value of Pretreatment
Sun Y; Qiao X; Jiang C; Liu S; Zhou Z
Contrast Media Mol Imaging; 2020; 2020():2981585. PubMed ID: 32922221
[TBL] [Abstract][Full Text] [Related]
18. Baseline
Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
[TBL] [Abstract][Full Text] [Related]
19. Methodological Aspects and the Prognostic Value of Metabolic Tumor Volume assessed with 18F-FDG PET/CT in Lymphomas.
Tutino F; Giovannini E; Pastorino S; Ferrando O; Giovacchini G; Ciarmiello A
Curr Radiopharm; 2022; 15(4):259-270. PubMed ID: 35352655
[TBL] [Abstract][Full Text] [Related]
20. Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma.
van Sluis J; de Heer EC; Boellaard M; Jalving M; Brouwers AH; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1498-1510. PubMed ID: 33099667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
